Collegium Pharmaceutical (COLL) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
1.43
1.71
1.98
2.25

Details

Expected EPS
1.524
Actual EPS
1.76
Surprise EPS
0.24
Surprise Percent
+15.49%

Description

Collegium Pharmaceutical (COLL) has reported earnings of 1.76 per share for Q2 2026.

0 Comments

Share your thoughts